Pharmacological treatment of nephrotic syndrome

Drugs of Today

Volumn 35, Issue 1, 1999, Pages 13-26

  Gauthier, Bernard ^a,b   Trachtman, Howard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LEVAMISOLE; PREDNISONE;

ALOPECIA; BONE MARROW DEPRESSION; CARCINOGENESIS; GASTROINTESTINAL TOXICITY; HEMORRHAGIC CYSTITIS; HUMAN; INFERTILITY; KIDNEY BIOPSY; NEPHROTIC SYNDROME; NEUTROPENIA; RASH; RELAPSE; REMISSION; REVIEW; SEIZURE;

EID: 0033055777     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.1.522942     Document Type: Review

References (84)

1. Farnsworth, E.B. Metabolic changes associated with administration of adrenocorticotropin in the nephrotic syndrome. Proc Soc Exp Biol 1950, 74: 60-2.
2. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981, 98: 561-4.
3. International Study of Kidney Disease in Children. Nephrotic syndrome in children: A randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. J Pediatr 1979, 95: 239-43.
4. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Lancet 1988, 1: 380-3.
5. Travis, L.B. The nephrotic syndrome. In: Rudolph's Pediatrics, 20th Ed. Rudolph, A.M., Hoffman, J.I.E., Rudolph, C.D., Sagan, P. (Eds.). Appleton & Lange: Stamford 1996, 1366-70.
6. Nash, M.A., Edelmann, C.M. Jr., Bernstein, J., Barnett, H.L. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity, and focal segmental glomerulosclerosis. In: Pediatric Kidney Disease, Second Ed. Edelman, C.M.J., Bernstein, J., Meadow, S.R., Spitzer, A., Travis, L.B. (Eds.). Little, Brown and Co.: Boston 1992, 1267-90.
7. Berry, P.L., Brewer, E.D. Glomerulonephritis and nephrotic syndrome. In: Principles and Practice of Pediatrics. Oski, F.A., DeAngelis, C.D., Feigin, R.D., Warshaw, J.B. (Eds.). Lippincott Co.: Philadelphia 1990, 1629-46.
8. Barratt, T.M., Clark, G. Minimal change nephrotic syndrome and focal segmental glomerulosclerosis. In: Pediatric Nephrology, Third Ed. Holliday, M.A., Barratt, T.M., Avner, E.D., Kogan, B.A. (Eds.). Williams & Wilkins: Baltimore 1994, 767-87.
9. Bergstein, J.M. Nephrotic syndrome. In: Nelson Textbook of Pediatrics, 15th Ed. Behrman, R.E., Kliegman, R.M., Arvin, A.M. (Eds.). WB Saunders Co.: Philadelphia 1996, 1500-2.
10. Kher, K.K. Nephrotic syndrome. In: Clinical Pediatric Nephrology. Kher, K.K., Makker, S.P. (Eds.). McGraw-Hill: New York 1992, 137-74.
11. Edelmann, C.M. Jr. An update on the International Study of Kidney Disease in Children. In: Pediatric Nephrology. Trachtman, H., Gauthier, B. (Eds.). Harwood Academic Publishers: Amsterdam 1998, 165-81.
12. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Alternate day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr 1981, 135: 229-37.
13. Enrich, J.H.H., Brodehl, J. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Eur J Pediatr 1993, 152: 357-61.
14. Ksiazek, J., Wyszynska, T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr Scand 1995, 84: 889-93.
15. Warshaw, B., Hymes, L. Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome. Pediatrics 1989, 83: 694-9.
16. Ekka, B.K., Bagga, A., Srivastava, R.N. Single versus divided dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 1997, 11: 597-9.
17. Ponticelli, C., Passerini, P. Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 1994, 46: 595-604.
18. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet 1974, 2: 423-7.
19. Tarshish, P., Tobin, J.N., Bernstein, J., Edelmann, C.M. Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997, 8: 769-76.
20. Srivastava, R.N., Vasudev, A.S., Bagga, A., Sunderam, K.R. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 1992, 6: 247-50.
21. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet 1979, 1: 401-3.
22. Nolasco, F., Cameron, J.S., Heywood, E.F., Hicks, J., Ogg, C., Williams, D.G. Adult-onset minimal change nephrotic syndrome: A long-term follow-up. Kidney Int 1986, 29: 1215-23.
23. Fujimoto, S., Yamamoto, Y., Hisanaga, S., Morita, S., Eto, T., Tanaka, K. Minimal change nephrotic syndrome in adults: Response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis 1991, 17: 687-92.
24. Korbet, S.M., Schwartz, M.M., Lewis, E.J. Minimal-change glomerulopathy of adulthood. Am J Nephrol 1988, 8: 291-7.
25. Wang, F., Looi, L.M., Chua, C.T. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy. Q J Med 1982, 51: 312-28.
26. Imbasciati, E., Gusmano, R., Edefonti, A. et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) 1985, 291: 1305-8.
27. Simon, P., Meyrier, A. One-year alternate day dosage of corticosteroid treatment reduces rate of further relapse in adult minimal change nephrosis. Kidney Int 1989, 35: Abst 201.
28. Glassock, R.J., Cohen, A.M., Adler, S.G. Primary glomerular disease. In: Brenner and Rector's The Kidney, 5th Ed. Brenner, B.M. (Ed.). WB Saunders Co.: Philadelphia 1996, 1392-497.
29. Wingen, A.M., Muller-Wiefel, D.E., Scharer, K. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome. Clin Nephrol 1985, 23: 35-40.
30. Postlethwaite, R.J., Houston, I.B., Powell, P.C. Spontaneous remission and delayed therapy in steroid-sensitive nephrotic syndrome. 12th Annu Meet Eur Soc Pediatr Nephrol (Kiryat Anavim, Israel) 1978, Abst 58.
31. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. New Engl J Med 1982, 306: 451-4.
32. Chiu, J., McLaine, P.N., Drummond, K.N. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 1973, 82: 607-13.
33. Barratt, T.M., Soothill, J.F. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 1970, 2: 479-82.
34. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Arch Dis Child 1987, 62: 1102-6.
35. Ueda, N., Kuno, K., Ito, S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990, 65: 1147-50.
36. Gauthier, B., Korn, S., Rousseau, T., Trachtman, H. Cyclophosphamide treatment of steroid dependent nephrotic syndrome in children. Child Hosp Q 1993, 5: 91-6.
37. Elhence, R., Gulati, S., Kher, V., Gupta, A., Sharma, R.K. Intravenous pulse cyclophosphamide - A new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 1994, 8: 1-3.
38. Fine, B.P., Munoz, R., Uy, C.S., Ty, A. Nitrogen mustard therapy in children with nephrotic syndrome unresponsive to corticosteroid therapy. J Pediatr 1976, 89: 1014-6.
39. Trainin, E.B., Boichis, H., Spitzer, A., Edelmann, C.M. Jr., Greifer, I. Late nonresponsiveness to steroids in children with the nephrotic syndrome. J Pediatr 1975, 87: 519-23.
40. McDonald, J., Murphy, A.V., Arneil, G.C. Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet 1974, 2: 980-2.
41. Grupe, W.E. Primary nephrotic syndrome in childhood. Adv Pediatr 1979, 26: 163-207.
42. McCrory, W.W., Shibuya, M., Lu, W.H., Lewy, J.E. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 1973, 82: 614-8.
43. Cameron, J.S., Ogg, C.S. Sterility and cyclophosphamide. Lancet 1972, 1: 1174-5.
44. Barratt, T.M., Cameron, J.S., Chantler, C., Ogg, C.S., Soothill, J.F. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Arch Dis Child 1973, 48: 286-90.
45. Baluarte, H.J., Hiner, L., Gruskin, A.B. Chlorambucil dosage in frequently relapsing nephrotic syndrome: A controlled clinical trial. J Pediatr 1978, 92: 295-8.
46. Schoeneman, M.J., Spitzer, A., Greifer, I. Nitrogen mustard therapy in children with frequent-relapsing nephrotic syndrome and steroid toxicity. Am J Kidney Dis 1983, 2: 526-9.
47. Guesry, P., Lenoir, G., Broyer, M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 1978, 92: 299-303.
48. Kleinknecht, C., Guesry, P., Lenoir, G., Broyer, M. High-cost benefit of chlorambucil in frequent relapsing nephrosis. New Engl J Med 1977, 296: 48-9.
49. Etteldorf, J.N., West, C.D., Pitcock, J.A., Williams, D.L. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr 1976, 88: 206-12.
50. Callis, L., Nieto, J., Vila, A., Rende, J. Chlorambucil treatment in minimal lesion nephrotic syndrome: A reappraisal of its gonadal toxicity. J Pediatr 1980, 97: 653-6.
51. Trompeter, R.S., Lloyd, B.W., Hicks, J., White, R.H., Cameron, J.S. Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 1985, 1: 368-70.
52. Williams, S.A., Makker, S.P., Grupe, W.E. Seizures: A significant side effect of chlorambucil therapy in children. J Pediatr 1978, 93: 516-8.
53. Jones, D.P., Stapleton, F.B., Roy, S. III, Wyatt, R.J. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome. Pediatr Nephrol 1988, 2: 291-5.
54. Niaudet, P., Broyer, M., Habib, R. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin Nephrol 1991, 35 (Suppl. 1): S31-6.
55. Brodehl, J., Brandis, M., Helmchen, U. et al. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 1988, 66: 1126-37.
56. Capodicasa, G., De Santo, N.G., Nuzzi, F., Giordano, C. Cyclosporin A in nephrotic syndrome of childhood - A 14 month experience. Int J Pediatr Nephrol 1986, 7: 69-72.
57. Pediatric Nephrology Group of the Spanish Society of Nephrology. Cyclosporine in the treatment of glomerulopathies in children. Multicenter survey. Nefrología 1990, 10 (Suppl. 5): 61-6.
58. Maher, E.R., Sweny, P., Chappel, M., Varghese, Z., Moorhead, J.F. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Nephrol Dial Transplant 1988, 3: 728-32.
59. Melocoton, T.L., Kamil, E.S., Cohen, A.H., Fine, R.N. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991, 18: 583-8.
60. Neuhaus, T.J., Burger, H.R., Klingler, M., Fanconi, A., Leumann, E.P. Long-term low-dose cyclosporin-A in steroid dependent nephrotic syndrome of childhood. Eur J Pediatr 1992, 151: 775-8.
61. Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J., Khawar, M.R. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988, 33: 729-34.
62. Green, A., O'Meara, Y., Sheehan, J., Carmody, M., Doyle, G., Donohoe, J. The use of cyclosporin A in adult nephrotic syndrome: Nine cases and literature review. Ir J Med Sci 1990, 159: 178-81.
63. Clasen, W., Kindler, J., Mihatsch, M.J., Sieberth, H.G. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: A control biopsy study. Nephrol Dial Transplant 1988, 3: 733-7.
64. Erbay, B., Karatan, O., Duman, N., Ertug, A.E. The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Transplant Proc 1988, 20 (3, Suppl. 4): 289-92.
65. Lagrue, C., Laurent, J., Belghiti, D., Robeva, R. Cyclosporin and idiopathic nephrotic syndrome. Lancet 1986, 2: 692-3.
66. Meyrier, A., Simon, P., Perret, G., Condamin, M.C. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Br Med J (Clin Res Ed) 1986, 292: 789-92.
67. Meyrier, A., Condamin, M.C., Broneer, D. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology. Clin Nephrol 1991, 35 (Suppl. 1): S37-42.
68. Glassock, R.J. Role of cyclosporine in glomerular diseases. Clevel Clin J Med 1994, 61: 363-9.
69. Meyrier, A. Treatment of idiopathic nephrotic syndrome with cyclosporine A. J Nephrol 1997, 10: 14-24.
70. Niaudet, P., Habib, R. Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 1994, 5: 1049-56.
71. Niaudet, P. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 1992, 6: 1-3.
72. Ponticelli, C., Edefonti, A., Ghio, L. et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 1993, 8: 1326-32.
73. Niaudet, P., Habib, R., Tete, M.J., Hinglais, N., Broyer, M. Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1987, 1: 566-73.
74. Tanphaichitr, P., Tanphaichitr, D., Sureeratanan, J., Chatasingh, S. Treatment of nephrotic syndrome with levamisole. J Pediatr 1980, 96: 490-3.
75. Niaudet, P., Drachman, R., Gagnadoux, M.F., Broyer, M. Treatment of idiopathic nephrotic syndrome with levamisole. Acta Paediatr Scand 1984, 73: 637-41.
76. Mongeau, J.G., Robitaille, P.O., Roy, F. Clinical efficacy of levamisole in the treatment of primary nephrosis in children. Pediatr Nephrol 1988, 2: 398-401.
77. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology. Lancet 1991, 337: 1555-7.
78. Mehta, K.P., Ali, U., Kutty, M., Kolhatkar, U. Immunoregulatory treatment for minimal change nephrotic syndrome. Arch Dis Child 1986, 61: 153-8.
79. Weiss, R. Randomized, double-blind, placebo controlled trial of levamisole for children with frequently relapsing/steroid dependent nephrotic syndrome. J Am Soc Nephrol 1993, 4: 289.
80. Bariety, J., Lagrue, C., Fritel, D., Milliez, P. Les agents alkylants et les antimétabolites dans les glomérulopathies. Soc Méd Hôp Paris 1966, 117: 963.
81. Abramowicz, M., Barnett, H.L., Edelmann, C.M. et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the International Study of Kidney Disease in Children. Lancet 1970, 1: 959-61.
82. Barratt, T.M., Cameron, J.S., Chantler, C., Counahan, R., Ogg, C.S., Soothill, J.F. Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. Arch Dis Child 1977, 52: 462-3.
83. Cade, R., Mars, D., Privette, M. et al. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Arch Intern Med 1986, 146: 737-41.
84. Kamil, E.S., Fredrich, R.K., Mougdil, A. et al. Chronic use of azathioprine (AZA) in difficult childhood nephrotic syndrome. J Am Soc Nephrol 1994, 5: Abst 353.